MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST) Files An 8-K Unregistered Sales of Equity Securities

MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST) Files An 8-K Unregistered Sales of Equity Securities

Item 3.02

Unregistered Sales of Equity Securities.

On June 16, 2017, Medifirst Solutions, Inc. (the Company) issued
450,000 shares of the Companys Series A Preferred Stock (the
Series A Preferred) to the Companys Chief Executive Officer,
Bruce Schoengood. The Series A Preferred are not convertible into
any series or class of stock of the Company. In addition, holders
of the Preferred A Stock are not entitled to receive dividends,
nor do they have rights to distribution from the assets of the
Company in the event of any liquidation, dissolution, or winding
up of the Company.

Each record holder of Series A Preferred have the right to vote
on any matter with holders of the Companys common stock and other
securities entitled to vote, if any, voting together as one (1)
class. Each record holder of Series A Preferred has that number
of votes equal to two thousand (2,000) votes per share of Series
A Preferred held by such holder.

The issuance of the Series A Preferred was made in reliance on an
exemption from registration under Section 4(a)(2) of the
Securities Act of 1933, as amended.

The foregoing description of the rights, preferences and
privileges of the Series A Preferred does not purport to be
complete and is subject to, and qualified in its entirety by
reference to Amended Certificate of Designation of Series A
Preferred Stock which is incorporated by reference to Exhibit 3.7
of the Companys report on Form 10-K filed April 14, 2016.


Medifirst Solutions, Inc. is a development-stage company. The Company is engaged in developing medical devices. The Company, under a manufacturing agreement, produces its hand-held mobile laser system known as The Time Machine Program. Through its subsidiary Medical Laser Manufacturer, Inc., the Company has entered into a Product and Know-How License Agreement (the License Agreement) with Laser Lab Corp to license the use of various properties in connection with seeking regulatory approval for and marketing, distributing and selling The Time Machine Series Lasers (TTM Series). In addition to the license granted to the Company, the License Agreement provides for an option to license other fields of use of the infrared laser in the TTM Series, as well as other wavelengths and colors, allowing the Company to develop a range of product offerings. The Time Machine Infrared Laser 810/830-nanometer (nm) operates in continuous wave mode set at a fixed frequency.

An ad to help with our costs